TNNT2 and adenocarcinoma: In this study, TNNT2 immunoreactivity was not observed in well-differentiated adenocarcinomas and keratinizing squamous cell carcinomas, and it seems likely that metastatic and/or recurrent neoplastic cells exhibit high prevalence of TNNT2 immunoreactivity.